Arabic Arabic English English French French German German
dark

Bioventus Proceeds with Option Structure Agreement with CartiHeal

Bioventus Inc. has elected to make a $50 million escrow payment pursuant to its Option and Equity Purchase Agreement with CartiHeal Ltd., signaling its intent to move forward with an acquisition of CartiHeal. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

How Pharma Startups Can Remain Competitive in Today’s Market

Next Post

Sonnet Announces Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate (SON-1410)

Related Posts
Total
0
Share